Biotech componentsGene Editing

Products 1 to 10 of 29

Bio-DEM™ by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Enzyme + Gene Editing + Microbe + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:33 (1 year ago)
Date last modified: 2019/09/12 14:33 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment + Venture Capital
Industry: Industrial + Multipurpose
Market status: On the market
Organization type(s): Private Company
Product categories: Additive + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Gene Editing
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/09/28 16:57 (2 years ago)
Known funding amount: 250,000 USD
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Gene Editing
Business models: B2C
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/08 14:47 (2 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
crPhage by Locus Biosciences
Biotech components: Gene Editing + Molecule + Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (1 year ago)
Date last modified: 2019/09/12 15:10 (1 year ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Health + Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Engineered Tilapia by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:57 (1 year ago)
Date last modified: 2019/09/12 14:59 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:47 (1 year ago)
Date last modified: 2019/09/12 14:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Novelty
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (7 months ago)
Date last modified: 2020/02/10 09:59 (7 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Hornless cattle by Recombinetics
Biotech components: Animal + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/01/21 15:00 (8 months ago)
Date last modified: 2020/01/21 15:00 (8 months ago)
Known funding amount: 34,000,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Animal
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/13 11:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/13 11:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical + Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input